CO4970740A1 - PIRIDAZINONE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASA BIOSYNTHESIS - Google Patents

PIRIDAZINONE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASA BIOSYNTHESIS

Info

Publication number
CO4970740A1
CO4970740A1 CO98047584A CO98047584A CO4970740A1 CO 4970740 A1 CO4970740 A1 CO 4970740A1 CO 98047584 A CO98047584 A CO 98047584A CO 98047584 A CO98047584 A CO 98047584A CO 4970740 A1 CO4970740 A1 CO 4970740A1
Authority
CO
Colombia
Prior art keywords
heterocyclic
alkyl
group
arylalkyl
cycloalkyl
Prior art date
Application number
CO98047584A
Other languages
Spanish (es)
Inventor
Lawrence A Black
Basha Anwer
Kolosa Teodozyj
Michael E Kort
Liu Huaqing
Carty Catherine M Mc
V Patel Meena
Jeffrey J Rohde
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO4970740A1 publication Critical patent/CO4970740A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula I: en dondeX se selecciona del grupo conformadopor O, S, NR4 , N-ORa , y N-NRb Rc , en donde R4 se selecciona del grupo conformado por alquil, alquenil, cicloalquil, cicloalquenil, cicloalquilalquil, cicloalquenilalquil, aril, heterocíclico, heterocíclico alquil, y arilalquil; y Ra , Rb , y Rc se seleccionan independientemente del grupo conformado por alquil, cicloalquil, cicloalquilalquil, aril, y arilalquil; R se selecciona del grupo conformado por alquil, alquenil, alquinil, alquilcarbonilalquil, alquilsulfonilalquil, alquilsulfonilarilalquil, alcoxi, alcoxialquil, carboxi, carboxialquil, cianoalquil, haloalquil, haloalquenil, haloalquinil, hidroxialquil, cicloalquil, cicloalquilalquil, cicloalquenil, cicloalquenilalquil, aril, arilalquil, arilalquenil, arilalquinil, arilalcoxi, arilhaloalquil, arilhidroxialquil, ariloxi, ariloxihidroxialquil, ariloxihaloalquil, arilcarbonilalquil, haloalcoxihidroxialquil, heterocíclico, heterocíclico alquil, heterocíclico alcoxi, heterocíclico oxi, -C(O)R5 , -(CH2 )n C(O)R5 , -R6 -R7 , -(CH2 )n CH(OH)R5 , (CH2 )n CH(ORd )R5 , (CH2 )n C(NORd )R5 , (CH2 )n C(NRd )R5 , -(CH2 )n CH(NORd )R5 , -(CH2 )n CH(NRd Re )R5 , -(CH2 )n CºC-R7 , -(CH2 )n [CH(CX´3 )]m -(CH2 )n -CX´3 , -(CH2 )n (CX´2 )m -(CH2 )n -CX´3 , -(CH2 )n [CH(CX´3 )]m -(CH2 )n R8 , -(CH2 )n (CX´2 )m -(CH2 )n -R8 , (CH2 )n (CHX´)m -(CH2 )n -CX´3 , -(CH2 )n (CHX´)m -(CH2 )n -R8 y -(CH2 )n -R20 , en donde R5 se selecciona del grupo conformado por alquil, alquenil, alquinil, cicloalquil, cicloalquenil, aril, arilalquil, haloalquil, haloalquenil, haloalquinil, heterocíclico, y heterocíclico alquil; en donde R6 es alquileno ó alquenileno, alquileno sustituido con halo ó alquenileno sustituido con halo; ...A compound of formula I: where X is selected from the group consisting of O, S, NR4, N-ORa, and N-NRb Rc, where R4 is selected from the group consisting of alkyl, alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, aryl, heterocyclic, heterocyclic alkyl, and arylalkyl; and Ra, Rb, and Rc are independently selected from the group consisting of alkyl, cycloalkyl, cycloalkylalkyl, aryl, and arylalkyl; R is selected from the group consisting of alkyl, alkenyl, alkynyl, alkylcarbonylalkyl, alquilsulfonilalquil, alquilsulfonilarilalquil, alkoxy, alkoxyalkyl, carboxy, carboxyalkyl, cyanoalkyl, haloalkyl, haloalkenyl, haloalkynyl, hydroxyalkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, arylalkyl, arylalkenyl , arylalkynyl, arylalkoxy, arylhaloalkyl, arylhydroxyalkyl, aryloxy, aryloxyhydroxyalkyl, aryloxyhaloalkyl, arylcarbonylalkyl, haloalkoxyhydroxyalkyl, heterocyclic, heterocyclic alkyl, heterocyclic alkoxy, heterocyclic oxy, -C () (C) -O () -R7, - (CH2) n CH (OH) R5, (CH2) n CH (ORd) R5, (CH2) n C (NORd) R5, (CH2) n C (NRd) R5, - (CH2) n CH (NORd) R5, - (CH2) n CH (NRd Re) R5, - (CH2) n CºC-R7, - (CH2) n [CH (CX´3)] m - (CH2) n -CX´3, - (CH2) n (CX´2) m - (CH2) n -CX´3, - (CH2) n [CH (CX´3)] m - (CH2) n R8, - (CH2) n (CX´ 2) m - (CH2) n -R8, (CH2) n (CHX´) m - (CH2) n -CX´3, - (CH2) n (CHX´) m - (CH2) n -R8 and - ( CH2 ) n -R20, where R5 is selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, haloalkyl, haloalkenyl, haloalquinyl, heterocyclic, and heterocyclic alkyl; wherein R6 is alkylene or alkenylene, halo-substituted alkylene, or halo-substituted alkenylene; ...

CO98047584A 1997-08-22 1998-08-20 PIRIDAZINONE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASA BIOSYNTHESIS CO4970740A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91702397A 1997-08-22 1997-08-22

Publications (1)

Publication Number Publication Date
CO4970740A1 true CO4970740A1 (en) 2000-11-07

Family

ID=25438243

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98047584A CO4970740A1 (en) 1997-08-22 1998-08-20 PIRIDAZINONE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASA BIOSYNTHESIS

Country Status (8)

Country Link
EP (1) EP1007515A1 (en)
BR (1) BR9812127A (en)
CA (1) CA2299300C (en)
CO (1) CO4970740A1 (en)
SA (1) SA98190764B1 (en)
TW (1) TWI232216B (en)
WO (1) WO1999010331A1 (en)
ZA (1) ZA987555B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525053B1 (en) * 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
RU2209813C2 (en) 1997-11-19 2003-08-10 Кова Ко., Лтд. Derivatives of pyridazine, medicinal agents based on thereof and method for treatment of arthritis
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
AU756275B2 (en) * 1998-08-14 2003-01-09 Nihon Nohyaku Co., Ltd. Pyridazinone derivatives
CN1279026C (en) * 1998-10-27 2006-10-11 艾博特公司 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
JP2000247959A (en) 1999-02-26 2000-09-12 Kowa Co Pyridazin-3-one derivative, and drug containing the same
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
ITMI20010733A1 (en) 2001-04-05 2002-10-05 Recordati Chem Pharm USE OF ISOENZIN COX-2 INHIBITORS FOR THE TREATMENT OF URINARY INCONTINENCE
CA2474239A1 (en) * 2002-01-18 2003-07-24 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
WO2004083188A1 (en) 2003-03-18 2004-09-30 Kowa Co., Ltd. Water-soluble phenylpyridazine derivative and medicine containing the same
ES2275218T3 (en) 2003-05-07 2007-06-01 Osteologix A/S HYDROSOLUBLE STRONTIUM SALTS FOR THE TREATMENT OF CARTILAGOS AND / OR BONE AFFECTIONS.
WO2005007632A1 (en) * 2003-07-18 2005-01-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
ES2324883T3 (en) 2004-06-09 2009-08-18 Sumitomo Chemical Company, Limited PIRIDAZINE COMPOSITE AND ITS USE.
WO2006001175A1 (en) 2004-06-28 2006-01-05 Sumitomo Chemical Company, Limited Pyridazine compound and use thereof
EP2591784B1 (en) 2005-05-10 2016-09-14 Intermune, Inc. Pyridine-2-one-derivatives as modulators of stress-activated protein kinase system
CA2623813A1 (en) * 2005-10-03 2007-04-12 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
EP1958948B1 (en) 2005-12-07 2011-10-05 Sumitomo Chemical Company, Limited Pyridazine compound and use thereof
AU2006322707B2 (en) 2005-12-07 2011-09-15 Sumitomo Chemical Company, Limited Pyridazine compound and use thereof
DE102007008843A1 (en) 2007-02-23 2008-08-28 Bayer Healthcare Ag Process for the preparation of 4,5-dihalo-2-aryl-2H-pyridazin-3-ones
DE102007008840A1 (en) * 2007-02-23 2008-08-28 Bayer Healthcare Ag Novel polymorphic form of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy) -5- [4-methylsulphonyl) phenyl] -3 (2H) -pyridazinone (FHMP)
DE102007008839A1 (en) 2007-02-23 2008-08-28 Bayer Healthcare Ag Process for the preparation of 4- (3-hydroxy-3-methylbutoxy) -5- [4- (methylsulfonyl) phenyl] -2-arylpyridazine-3 (2H) -ones
DE102007020690A1 (en) * 2007-05-03 2008-11-06 Bayer Healthcare Ag New amorphous form of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy) -6 [4-methylsulfonyl) phenyl] -3 (2H) -pyridazinone (FHMP)
DE102007020689A1 (en) * 2007-05-03 2008-11-06 Bayer Healthcare Ag Novel polymorphic form of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy-5- [4-methylsulfonyl) phenyl] 3 / 2H) -pyridazinone (FHMP)
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
JO3115B1 (en) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co Pyridazinone Compounds and Their Use as DAAO Inhibitors
JP6169492B2 (en) 2011-11-15 2017-07-26 武田薬品工業株式会社 Dihydroxy aromatic heterocyclic compounds
AR092742A1 (en) 2012-10-02 2015-04-29 Intermune Inc ANTIFIBROTIC PYRIDINONES
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009675A1 (en) * 1987-06-05 1988-12-15 Medicis Corporation Inhibition of arachidonic acid metabolism
AU691673B2 (en) * 1994-11-14 1998-05-21 Dow Agrosciences Llc Pyridazinones and their use as fungicides
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents

Also Published As

Publication number Publication date
BR9812127A (en) 2000-07-18
EP1007515A1 (en) 2000-06-14
CA2299300C (en) 2007-04-17
SA98190764B1 (en) 2006-08-06
WO1999010331A1 (en) 1999-03-04
ZA987555B (en) 1999-02-23
CA2299300A1 (en) 1999-03-04
TWI232216B (en) 2005-05-11

Similar Documents

Publication Publication Date Title
CO4970740A1 (en) PIRIDAZINONE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASA BIOSYNTHESIS
MY100731A (en) Tetrahydrophthalimides, and their production and use
BG101917A (en) New taxoids, their preparation and pharmaceutical compositions containing them
AU637138B2 (en) Quinone derivatives and pharmacological use
TW324008B (en) Pyridone sulfonylurea compound, its production process and weed killer containing such compound
UA27254C2 (en) Dipeptide compounds and processes for preparation thereof
MY106071A (en) Method for preparation of taxol using an oxazinone.
HK1008529A1 (en) Pentacyclic compounds
CO5040012A1 (en) DAILY ESTERS AND PROCESSES FOR THE PREPARATION AND COMPOSITION OF HERBICIDES AND DISKERS CONTAINING THEM
IE43450L (en) 6, 7-benzomorphans
HU913392D0 (en) Amino-glycoside substance with decreased nephrotoxicity
ES2003651A6 (en) Thiadiazabicyclononane derivatives, processes for their production and herbizidal compositions.
MY101877A (en) Benzoylurea compounds and pesticidal and pharmaceutical compositions comprising same
IL93480A0 (en) Substituted oxime ethers and fungicides containing same
AR015422A1 (en) BIOSYNTHESIS INHIBITORS OF PROSTAGLANDINA ENDOPEROXIDO H SINTASA, A METHOD FOR OBTAINING IT, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT
GR3003646T3 (en)
ES451484A1 (en) N-(1,2,4-Triazin-5-on-4-yl)-glycines and herbicidal compositions
ES8405367A1 (en) Novel N-nitroso compounds, compositions containing such compounds and processes for their preparation.
EP0372891A3 (en) Optically active compounds and a process for producing these compounds
JPS6442429A (en) Remedy for entamoeba histolytica